boc-glycine has been researched along with n-benzyloxycarbonylglycine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asser, AS; Baumgart, LE; Carballo, N; Carpenter, SE; Chew, GH; Cosner, CC; Dusi, J; Galloway, LC; Kendig, RD; King, L; Kline, PC; Lowe, AB; Lowe, EW; Malka, R; McIntyre, NR; Merkler, DJ; Merkler, KA; Owen, TC; Romero, M; Wilcox, BJ | 1 |
| Dumont, P; Lambert, DM; Maloteaux, JM; Poupaert, JH | 1 |
2 other study(ies) available for boc-glycine and n-benzyloxycarbonylglycine
| Article | Year |
|---|---|
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).
Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Hippurates; Humans; Inhibitory Concentration 50; Insecticides; Mixed Function Oxygenases; Models, Molecular; Multienzyme Complexes; Rats; Structure-Activity Relationship; Tumor Cells, Cultured | 2008 |
Anticonvulsant activities of N-benzyloxycarbonylglycine after parenteral administration.
Topics: Animals; Anticonvulsants; Binding, Competitive; Electroshock; Glycine; Infusions, Parenteral; Male; Mice; Mice, Inbred Strains; Receptors, Glycine; Seizures | 1994 |